Cargando…
OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM)
BACKGROUND: MBM have a unique molecular profile compared to ECM. METHODS: We analyzed a previously published dataset from MD Anderson Cancer Center, including RNA-seq on surgically resected, FFPE MBM and ECM from the same patients. STAR pipeline was used to estimate mRNA abundance. DESeq2 package wa...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351192/ http://dx.doi.org/10.1093/noajnl/vdab071.069 |
_version_ | 1783735920030121984 |
---|---|
author | Kennedy, Lucy Boyce Van Swearingen, Amanda E D Sheng, Jeff Zhang, Dadong Qin, Xiaodi Lipp, Eric Kumar, Swaminathan Zhang, Gao Hanks, Brent Davies, Michael Owzar, Kouros Anders, Carey K Salama, April K S |
author_facet | Kennedy, Lucy Boyce Van Swearingen, Amanda E D Sheng, Jeff Zhang, Dadong Qin, Xiaodi Lipp, Eric Kumar, Swaminathan Zhang, Gao Hanks, Brent Davies, Michael Owzar, Kouros Anders, Carey K Salama, April K S |
author_sort | Kennedy, Lucy Boyce |
collection | PubMed |
description | BACKGROUND: MBM have a unique molecular profile compared to ECM. METHODS: We analyzed a previously published dataset from MD Anderson Cancer Center, including RNA-seq on surgically resected, FFPE MBM and ECM from the same patients. STAR pipeline was used to estimate mRNA abundance. DESeq2 package was used to perform differential gene expression (DGE) analyses. Pathway analysis was performed using Gene Set Enrichment Analysis (GSEA). Paired DGE and GSEA compared MBM vs. lymph node (LN) metastases (n = 16) and MBM vs. skin mets (n = 10). CIBERSORTx estimated relative abundance of immune cell types in MBM and ECM. GATK Mutect2 pipeline was used to call somatic mutations using paired normal tumor samples. Mutations were annotated using the Ensembl Variant Effect Predictor and visualized using the Maftools package in R. RNA-seq was available on 54 human primary cutaneous melanomas (CM). Gene Ontology or KEGG Pathway analysis was performed using goana function of limma package in R. RESULTS: Paired GSEA found that autophagy pathways may be up-regulated in MBM vs. LN and MBM vs. skin mets. On a single-gene level, the most strongly up-regulated genes in autophagy pathways were GFAP and HBB. Fold changes in other autophagy-related genes were low and did not reach significance. Comparison between CM which recurred in brain vs. CM which did not recur identified up-regulation of autophagy pathways. CIBERSORTx identified an increased proportion of immune suppressive M2 macrophages compared to tumor suppressive M1 macrophages in MBMs and ECMs. CONCLUSION: Up-regulation of autophagy pathways was observed in patient-matched MBM vs. LN and skin mets. This finding was driven by up-regulation of GFAP and HBB, which could reflect changes in the tumor microenvironment. Higher M2:M1 ratio may contribute to an immune suppressive tumor microenvironment and may be targetable. Validation of our findings in an independent Duke dataset is ongoing. |
format | Online Article Text |
id | pubmed-8351192 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-83511922021-08-09 OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM) Kennedy, Lucy Boyce Van Swearingen, Amanda E D Sheng, Jeff Zhang, Dadong Qin, Xiaodi Lipp, Eric Kumar, Swaminathan Zhang, Gao Hanks, Brent Davies, Michael Owzar, Kouros Anders, Carey K Salama, April K S Neurooncol Adv Supplement Abstracts BACKGROUND: MBM have a unique molecular profile compared to ECM. METHODS: We analyzed a previously published dataset from MD Anderson Cancer Center, including RNA-seq on surgically resected, FFPE MBM and ECM from the same patients. STAR pipeline was used to estimate mRNA abundance. DESeq2 package was used to perform differential gene expression (DGE) analyses. Pathway analysis was performed using Gene Set Enrichment Analysis (GSEA). Paired DGE and GSEA compared MBM vs. lymph node (LN) metastases (n = 16) and MBM vs. skin mets (n = 10). CIBERSORTx estimated relative abundance of immune cell types in MBM and ECM. GATK Mutect2 pipeline was used to call somatic mutations using paired normal tumor samples. Mutations were annotated using the Ensembl Variant Effect Predictor and visualized using the Maftools package in R. RNA-seq was available on 54 human primary cutaneous melanomas (CM). Gene Ontology or KEGG Pathway analysis was performed using goana function of limma package in R. RESULTS: Paired GSEA found that autophagy pathways may be up-regulated in MBM vs. LN and MBM vs. skin mets. On a single-gene level, the most strongly up-regulated genes in autophagy pathways were GFAP and HBB. Fold changes in other autophagy-related genes were low and did not reach significance. Comparison between CM which recurred in brain vs. CM which did not recur identified up-regulation of autophagy pathways. CIBERSORTx identified an increased proportion of immune suppressive M2 macrophages compared to tumor suppressive M1 macrophages in MBMs and ECMs. CONCLUSION: Up-regulation of autophagy pathways was observed in patient-matched MBM vs. LN and skin mets. This finding was driven by up-regulation of GFAP and HBB, which could reflect changes in the tumor microenvironment. Higher M2:M1 ratio may contribute to an immune suppressive tumor microenvironment and may be targetable. Validation of our findings in an independent Duke dataset is ongoing. Oxford University Press 2021-08-09 /pmc/articles/PMC8351192/ http://dx.doi.org/10.1093/noajnl/vdab071.069 Text en © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Supplement Abstracts Kennedy, Lucy Boyce Van Swearingen, Amanda E D Sheng, Jeff Zhang, Dadong Qin, Xiaodi Lipp, Eric Kumar, Swaminathan Zhang, Gao Hanks, Brent Davies, Michael Owzar, Kouros Anders, Carey K Salama, April K S OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM) |
title | OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM) |
title_full | OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM) |
title_fullStr | OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM) |
title_full_unstemmed | OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM) |
title_short | OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM) |
title_sort | othr-14. an immunogenomic analysis of melanoma brain metastases (mbm) compared to extracranial metastases (ecm) |
topic | Supplement Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351192/ http://dx.doi.org/10.1093/noajnl/vdab071.069 |
work_keys_str_mv | AT kennedylucyboyce othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm AT vanswearingenamandaed othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm AT shengjeff othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm AT zhangdadong othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm AT qinxiaodi othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm AT lipperic othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm AT kumarswaminathan othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm AT zhanggao othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm AT hanksbrent othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm AT daviesmichael othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm AT owzarkouros othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm AT anderscareyk othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm AT salamaaprilks othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm |